8/4/2022 12:30:05 PM - Gapped up for a 2nd consecutive gain today after rebounding above its 200 DMA line ($98.77) on the prior session while the mid-day report cautioned members - "Reported earnings -1% and +11% sales revenues for the Jun '22 quarter versus the year ago period and fundamental concerns remain."
8/3/2022 12:08:26 PM - Gapped up today and rebounded above its 200 DMA line ($98.67). Reported earnings -1% and +11% sales revenues for the Jun '22 quarter versus the year ago period and fundamental concerns remain.
7/19/2022 12:20:27 PM - Rebounded above its 50 DMA line ($94.75) with recent gains lacking great volume conviction, but remains below its 200 DMA line ($98.04). Reported earnings +9% and +11% sales revenues for the Mar '22 quarter versus the year ago period and fundamental concerns remain.
1/8/2020 12:22:35 PM - Slumping below its 50 DMA line ($73.04) with today's loss. Reported earnings +6% and +36% sales revenues for the Sep '19 quarter. Went through a deep consolidation since the 11/30/18 mid-day report cautioned members - "Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
12/10/2019 12:54:14 PM - Reported earnings +6% and +36% sales revenues for the Sep '19 quarter. Consolidating after rebounding toward its 52-week high. Went through a deep consolidation since the 11/30/18 mid-day report cautioned members - "Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
11/29/2019 11:02:40 AM - Reported earnings +6% and +36% sales revenues for the Sep '19 quarter. Rebounding toward its 52-week high. Went through a deep consolidation since the 11/30/18 mid-day report cautioned members - "Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
11/7/2019 12:35:13 PM - Rebounding toward its 52-week high. Went through a deep consolidation since the 11/30/18 mid-day report cautioned members - "Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
11/6/2019 12:10:32 PM - Rebounding toward its 52-week high. Went through a deep consolidation since the 11/30/18 mid-day report cautioned members - "Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
12/13/2018 12:42:27 PM - Slumping well below its 50 DMA line since rallying to challenge its 52-week high when the 11/30/18 mid-day report cautioned members - " Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
12/10/2018 12:42:39 PM - Slumping well below its 50 DMA line since rallying to challenge its 52-week high when the 11/30/18 mid-day report cautioned members - " Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
11/30/2018 12:22:20 PM - Rebounded above its 50 DMA line to challenge its 52-week high with this week's volume-driven gains. Prior mid-day reports cautioned members - " Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
11/28/2018 12:41:43 PM - Rebounding above its 50 DMA line with this week's streak of volume-driven gains. Prior mid-day reports cautioned members - " Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
11/27/2018 12:42:46 PM - Rebounding above its 50 DMA line with this week's gains. Prior mid-day reports cautioned members - " Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
11/26/2018 12:46:46 PM - Rebounding above its 50 DMA line. Prior mid-day reports cautioned members - " Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern. Earnings growth below guidelines."
11/20/2018 12:09:38 PM - Gapped down today and it is undercutting its 50 DMA line ($76.70). Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Sub par sales revenues growth is a concern and prior mid-day reports cautioned members - "Earnings growth below guidelines."
11/6/2018 12:07:04 PM - Gapped up today and it is rebounding above its 50 DMA line ($75.86). Fundamental concerns remain. Reported Sep '18 quarterly earnings +15% on +2% sales revenues versus the year ago period. Fundamental concerns remain due to sub par sales revenues growth and prior mid-day reports cautioned members - "Earnings growth below guidelines."
10/11/2018 12:22:40 PM - Gapped down today testing its 50 DMA line ($75). Fundamental concerns remain. Reported Jun '18 quarterly earnings +27% on +2% sales revenues versus the year ago period. Fundamental concerns remain due to sub par sales revenues growth and prior mid-day reports cautioned members - "Earnings growth below guidelines."
8/4/2015 12:21:22 PM - Gapped down today. Fundamental concerns remain while its Jun '15 quarterly earnings were +8% on +7% sales revenues versus the year ago period. Prior mid-day reports cautioned members -"Earnings growth below guidelines."
10/16/2014 12:24:26 PM - Violated its 50 DMA line with a gap down and volume-driven loss on the prior session. Fundamental concerns remain while its Jun '14 quarterly earnings were +16% on +11% sales revenues versus the year ago period. Prior mid-day reports cautioned members -"Earnings growth below guidelines."
10/14/2014 12:11:51 PM - Retreated from new 52-week and all-time highs, again testing support near its 50 DMA line. Fundamental concerns remain while its Jun '14 quarterly earnings were +16% on +11% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report -"Earnings growth below guidelines."
9/4/2014 12:14:12 PM - Hitting new 52-week and all-time highs with today's 7th consecutive small gain. Recently found support near its 50 DMA line. Fundamental concerns remain while its Jun '14 quarterly earnings were +16% on +11% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report -"Earnings growth below guidelines."
8/6/2014 12:14:34 PM - Perched near its 52-week and all-time highs, churning heavy volume in a wider than usual intra-day trading range while finding support near its 50 DMA line. Fundamental concerns remain while its Jun '14 quarterly earnings were +16% on +11% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report -"Earnings growth below guidelines."
8/5/2014 11:54:43 AM - Perched near its 52-week and all-time highs, forming an orderly base and finding support near its 50 DMA line. Fundamental concerns remain while its Mar '14 quarterly earnings were +23% on +6% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report -"Earnings growth below guidelines."
7/28/2014 12:17:22 PM - Perched near its 52-week and all-time highs after forming an orderly base and finding support near its 50 DMA line. Fundamental concerns remain while its Mar '14 quarterly earnings were +23% on +6% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report -"Earnings growth below guidelines."
7/19/2012 11:40:42 AM - Gapped down today, abruptly reversing from new 52-week and all-time highs after recently wedging to new high territory without great volume conviction behind a streak of consecutive small gains. Prior mid-day reports noted - "Fundamental (earnings growth) concerns still apply through its Mar '12 quarterly results after the Retail - Drug Store firm reported earnings +14% on +20% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report - 'Earnings growth below guidelines.'"
7/9/2012 12:02:26 PM - Pulling back from new 52-week and all-time highs today after recently wedging to new high territory without great volume conviction behind a streak of 8 consecutive small gains. Last noted in the 5/18/12 mid-day report - "Fundamental (earnings growth) concerns still apply through its Mar '12 quarterly results after the Retail - Drug Store firm reported earnings +14% on +20% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report - 'Earnings growth below guidelines.'"
5/18/2012 12:17:01 PM - Hovering near its 52-week and all-time highs, encountering recent distributional pressure yet holding its ground above its 50 DMA line. Fundamental (earnings growth) concerns still apply through its Mar '12 quarterly results after the Retail - Drug Store firm reported earnings +14% on +20% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report - "Earnings growth below guidelines."
5/2/2012 12:34:08 PM - Hitting new 52-week and all-time highs today. It survived but failed to impress since last noted, and fundamental concerns still apply through its Mar '12 financial results, as was the case when noted in the 5/06/08 mid-day report - "Earnings growth below guidelines."
5/6/2008 12:32:06 PM - Remains perched near its prior chart highs ($42 area). Earnigns growth below guidelines.
10/25/2007 1:09:08 PM - Climbing to new highs with gains on quiet volume after finding support near its 50 DMA line recently. The company reaffirmed its earnings guidance, but fell on 10/01/07 after a key competitor, rival drugstore operator Walgreen Co. (WAG), said its fourth-quarter profit dropped 4 percent, in part on lower reimbursements on generic drugs.
10/18/2007 12:47:25 PM - Hovering near its recent highs after finding support near its 50 DMA line. The company reaffirmed its earnings guidance, but fell on 10/01/07 after a key competitor, rival drugstore operator Walgreen Co. (WAG), said its fourth-quarter profit dropped 4 percent, in part on lower reimbursements on generic drugs.
10/1/2007 12:53:36 PM - Gapped down for a loss on heavy volume but recovered from lows and seems to be finding support near its 50 DMA line. The company reaffirmed its earnings guidance, but fell after a key competitor, rival drugstore operator Walgreen Co. (WAG -14.4%), said its fourth-quarter profit dropped 4 percent, in part on lower reimbursements on generic drugs.
5/25/2007 1:18:14 PM - No base.